• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微创肝切除术在复发性 HCC 中是否是一种合理的选择?来自 I Go MILS 登记处的快照。

Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry.

机构信息

Division of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Italy.

Hepatobiliary Surgery, IRCCS San Raffaele Hospital, Milan, Italy.

出版信息

Updates Surg. 2022 Feb;74(1):87-96. doi: 10.1007/s13304-021-01161-w. Epub 2021 Oct 3.

DOI:10.1007/s13304-021-01161-w
PMID:34601669
Abstract

Laparoscopic liver resection (LLR) for Hepatocellular carcinoma (HCC) is a safe procedure. Repeat surgery is more often required, and the role of minimally invasive liver surgery (MILS) is not yet clearly defined. The present study analyzes data compiled by the Italian Group of Minimally Invasive Liver Surgery (IGoMILS) on LLR. To compare repeated LLR with the first LLR for HCC is the primary endpoint. The secondary endpoint was to evaluate the outcome of repeat LLR in the case of primary open versus primary MILS surgery. The data cohort is divided into two groups. Group 1: first liver resection and Group 2: Repeat LLR. To compare the two groups a 3:1 Propensity Score Matching is performed to analyze open versus MILS primary resection. Fifty-two centers were involved in the present study, and 1054 patients were enrolled. 80 patients underwent to a repeat LLR. The type of resection was different, with more major resections in the group 1 before matching the two groups. After propensity score matching 3:1, each group consisted of 222 and 74 patients. No difference between the two groups was observed. In the subgroup analysis, in 44 patients the first resection was performed by an open approach. The other 36 patients were resected with a MILS approach. We found no difference between these two subgroups of patients. The present study in repeat MILS for HCC using the IGoMILS Registry has observed the feasibility and safety of the MILS procedure.

摘要

腹腔镜肝切除术(LLR)治疗肝细胞癌(HCC)是一种安全的手术方法。重复手术更为常见,微创肝手术(MILS)的作用尚未明确。本研究分析了意大利微创肝外科组(IGoMILS)关于 LLR 的数据。比较 HCC 患者重复 LLR 与首次 LLR 的结果是主要终点。次要终点是评估首次开腹与首次 MILS 手术治疗 HCC 时重复 LLR 的结果。该数据队列分为两组。组 1:首次肝切除术,组 2:重复 LLR。为了比较两组,采用 3:1 倾向评分匹配分析开腹与 MILS 原发性切除术。本研究涉及 52 个中心,共纳入 1054 例患者。80 例患者接受了重复 LLR。在匹配两组之前,组 1 的手术类型不同,主要切除术更多。经过倾向评分匹配 3:1 后,每组各有 222 例和 74 例患者。两组之间没有观察到差异。在亚组分析中,44 例患者首次开腹手术。其他 36 例患者接受 MILS 手术。我们没有发现这两组患者之间有差异。本研究使用 IGoMILS 登记处对 HCC 重复 MILS 进行分析,观察到 MILS 手术的可行性和安全性。

相似文献

1
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry.微创肝切除术在复发性 HCC 中是否是一种合理的选择?来自 I Go MILS 登记处的快照。
Updates Surg. 2022 Feb;74(1):87-96. doi: 10.1007/s13304-021-01161-w. Epub 2021 Oct 3.
2
Technical feasibility and short-term outcomes of laparoscopic isolated caudate lobe resection: an IgoMILS (Italian Group of Minimally Invasive Liver Surgery) registry-based study.腹腔镜孤立尾状叶切除术的技术可行性和短期结果:一项基于 IgoMILS(意大利微创肝外科组)登记研究。
Surg Endosc. 2022 Feb;36(2):1490-1499. doi: 10.1007/s00464-021-08434-w. Epub 2021 Mar 31.
3
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry.腹腔镜肝切除术治疗位于不利部位的肝细胞癌:来自意大利微创肝外科组(I Go MILS)登记处的倾向评分匹配分析。
Surg Endosc. 2019 May;33(5):1451-1458. doi: 10.1007/s00464-018-6426-3. Epub 2018 Sep 10.
4
Robotic and laparoscopic liver resection-comparative experiences at a high-volume German academic center.机器人和腹腔镜肝切除术——德国一家高容量学术中心的比较经验。
Langenbecks Arch Surg. 2021 May;406(3):753-761. doi: 10.1007/s00423-021-02152-6. Epub 2021 Apr 8.
5
Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO).腹腔镜与开腹局限性肝切除术治疗肝硬化肝细胞癌的比较:来自广岛临床肿瘤外科学会(HiSCO)的倾向评分匹配研究。
Surg Endosc. 2020 Nov;34(11):5055-5061. doi: 10.1007/s00464-019-07302-y. Epub 2019 Dec 11.
6
Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a multi-centre propensity score-based analysis.腹腔镜与开腹肝切除术治疗老年肝细胞癌的多中心倾向评分分析。
Surg Endosc. 2020 Feb;34(2):658-666. doi: 10.1007/s00464-019-06812-z. Epub 2019 May 15.
7
Minimally invasive treatment of colorectal liver metastases: does robotic surgery provide any technical advantages over laparoscopy? A multicenter analysis from the IGoMILS (Italian Group of Minimally Invasive Liver Surgery) registry.结直肠肝转移的微创治疗:机器人手术相对于腹腔镜手术是否具有任何技术优势?来自 IGoMILS(意大利微创肝外科组)注册中心的多中心分析。
Updates Surg. 2022 Apr;74(2):535-545. doi: 10.1007/s13304-022-01245-1. Epub 2022 Jan 31.
8
Short and long-term outcomes after minimally invasive liver resection for single small hepatocellular carcinoma: An analysis of 714 patients from the IGoMILS (Italian group of minimally invasive liver surgery) registry.单发性小肝细胞癌微创肝切除术后的短期和长期结果:来自 IGoMILS(意大利微创肝外科组)注册研究的 714 例患者分析。
HPB (Oxford). 2023 Jun;25(6):674-683. doi: 10.1016/j.hpb.2023.02.007. Epub 2023 Feb 24.
9
Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis.肝细胞癌的小范围腹腔镜肝切除术比小范围开放性肝切除术更安全,尤其对于肝功能代偿较差的肝硬化患者:倾向评分分析
Surg Oncol. 2018 Dec;27(4):722-729. doi: 10.1016/j.suronc.2018.10.001. Epub 2018 Oct 3.
10
Long-term surgical outcomes in patients with hepatocellular carcinoma undergoing laparoscopic vs. open liver resection: A retrospective and propensity score-matched study.腹腔镜与开腹肝切除术治疗肝细胞癌患者的长期手术结果:回顾性和倾向评分匹配研究。
Asian J Surg. 2021 Jan;44(1):206-212. doi: 10.1016/j.asjsur.2020.05.028. Epub 2020 Jun 9.

引用本文的文献

1
Essential updates 2022/2023: A review of current topics in robotic hepatectomy.2022/2023年重要更新:机器人肝切除术当前主题综述
Ann Gastroenterol Surg. 2024 Jun 21;8(5):774-777. doi: 10.1002/ags3.12817. eCollection 2024 Sep.
2
Robotic Complete ALPPS (rALPPS)-First German Experiences.机器人辅助完全ALPPS(rALPPS)——德国的首例经验
Cancers (Basel). 2024 Mar 6;16(5):1070. doi: 10.3390/cancers16051070.
3
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues.肝细胞癌移植后复发的治疗方法:确定因素与未决问题

本文引用的文献

1
Low Intensity Extracorporeal Shock Wave Therapy as a Novel Treatment for Stress Urinary Incontinence: A Randomized-Controlled Clinical Study.低强度体外冲击波疗法治疗压力性尿失禁的随机对照临床试验。
Medicina (Kaunas). 2021 Sep 8;57(9):947. doi: 10.3390/medicina57090947.
2
Phase II Prospective Study of Trastuzumab in Combination with S-1 and Oxaliplatin (SOX100) Therapy for HER2-Positive Advanced Gastric Cancer.曲妥珠单抗联合 S-1 和奥沙利铂(SOX100)治疗 HER2 阳性晚期胃癌的 II 期前瞻性研究。
J Gastrointest Cancer. 2022 Dec;53(4):930-938. doi: 10.1007/s12029-021-00711-0. Epub 2021 Sep 22.
3
Laparoscopic repeat hepatectomy is a more favorable treatment than open repeat hepatectomy for contralateral recurrent hepatocellular carcinoma cases.
Cancers (Basel). 2023 Nov 26;15(23):5593. doi: 10.3390/cancers15235593.
4
Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: a systematic review of propensity score-matched studies.腹腔镜与开腹肝切除术治疗肝内胆管细胞癌:倾向评分匹配研究的系统评价。
Updates Surg. 2023 Dec;75(8):2049-2061. doi: 10.1007/s13304-023-01648-8. Epub 2023 Nov 2.
5
Ten years of Italian mini-invasiveness: the I Go MILS registry as a tool of dissemination, characterization and networking.十年的意大利微创探索:I Go MILS 登记作为传播、特征和网络构建的工具。
Updates Surg. 2023 Sep;75(6):1457-1469. doi: 10.1007/s13304-023-01597-2. Epub 2023 Jul 24.
6
Propensity Score Matching Analysis of the Safety of Completion Total Pancreatectomy for Remnant Pancreatic Tumors Versus that of Initial Total Pancreatectomy for Primary Pancreatic Tumors.完成性全胰切除术治疗残胰肿瘤与初始性全胰切除术治疗原发性胰腺肿瘤安全性的倾向评分匹配分析。
Ann Surg Oncol. 2023 Jul;30(7):4392-4406. doi: 10.1245/s10434-023-13309-6. Epub 2023 Mar 18.
7
Challenging Scenarios and Debated Indications for Laparoscopic Liver Resections for Hepatocellular Carcinoma.肝细胞癌腹腔镜肝切除术的挑战性场景及存在争议的适应证
Cancers (Basel). 2023 Feb 27;15(5):1493. doi: 10.3390/cancers15051493.
8
Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma.病例报告:采用转化治疗以实现对最初无法切除的肝细胞癌的切除。
Front Oncol. 2022 Oct 6;12:946693. doi: 10.3389/fonc.2022.946693. eCollection 2022.
腹腔镜再次肝切除术是治疗对侧复发性肝细胞癌的更有利的治疗方法,优于开腹再次肝切除术。
Surg Endosc. 2021 Jun;35(6):2896-2906. doi: 10.1007/s00464-020-07728-9. Epub 2020 Jun 16.
4
Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients.预测非肌层浸润性膀胱癌(Ta-T1期)的复发:一项基于477例患者的研究。
Medicine (Baltimore). 2019 Jul;98(28):e16426. doi: 10.1097/MD.0000000000016426.
5
Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: single center experience of 90 cases.肝硬化患者肝细胞癌的腹腔镜肝切除术:单中心90例经验
Hepatobiliary Surg Nutr. 2015 Oct;4(5):320-4. doi: 10.3978/j.issn.2304-3881.2015.06.13.